Algernon Pharmaceuticals Inc (AGNPF)

[carramrod]

Maybe it is just me and someone can ease my concern with some insight, but I am still a little hung up on this enrollment rate. I do agree, it was nice to hear Chris let the market know they will be releasing interim data early December. But. Just a couple weeks ago we all expected trial completion and a full data read out by end of year. And I still don't feel like we have gotten a good explanation of why that changed. Why is enrollment not at 100%?

.

In the last video put out by the company, Chris mentioned the issues with hitting full enrollment had to do with patients falling out of the trial/not staying in for the full duration of 14 days. However, in the video prior, he mentioned there was certain qualifications people had to meet and made it seem like that was the issue. What is it?

Shoot me straight, Chris.